NYSE:GOOSCanada Goose Stock Price, Forecast & News

Canada Goose's stock was trading at $19.74 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, GOOS shares have increased by 5.3% and is now trading at $20.78. View which stocks have been most impacted by Coronavirus.

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Canada Goose in the last year. There are currently 1 sell rating, 2 hold ratings and 11 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Canada Goose.

Canada Goose is scheduled to release its next quarterly earnings announcement on Wednesday, June 3rd 2020. View our earnings forecast for Canada Goose.

Canada Goose Holdings Inc (NYSE:GOOS) announced its earnings results on Wednesday, November, 13th. The company reported $0.57 EPS for the quarter, beating analysts' consensus estimates of $0.35 by $0.22. The firm had revenue of $294 million for the quarter, compared to the consensus estimate of $267.29 million. Canada Goose had a net margin of 16.32% and a return on equity of 41.68%. Canada Goose's revenue for the quarter was up 27.7% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.46 earnings per share. View Canada Goose's earnings history.

Canada Goose updated its FY20 earnings guidance on Tuesday, March, 17th. The company provided EPS guidance of $1.33-1.37 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.35. The company issued revenue guidance of $945-955 million, compared to the consensus revenue estimate of $950.29 million.

14 brokerages have issued 1 year price targets for Canada Goose's stock. Their forecasts range from $21.00 to $62.00. On average, they expect Canada Goose's stock price to reach $37.33 in the next twelve months. This suggests a possible upside of 79.7% from the stock's current price. View analysts' price targets for Canada Goose.

Media stories about GOOS stock have trended somewhat negative on Wednesday, according to InfoTrie Sentiment. The research firm ranks the sentiment of news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Canada Goose earned a media sentiment score of -1.0 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the near future. View the latest news aboutCanada Goose.

Canada Goose saw a decrease in short interest in the month of May. As of May 15th, there was short interest totaling 9,630,000 shares, a decrease of 6.0% from the April 30th total of 10,250,000 shares. Based on an average daily trading volume, of 2,530,000 shares, the short-interest ratio is currently 3.8 days. Currently, 16.9% of the shares of the company are sold short. View Canada Goose's Current Options Chain.

Some companies that are related to Canada Goose include LI NING CO LTD/ADR (LNNGY), Levi Strauss & Co. (LEVI), Columbia Sportswear (COLM), Under Armour (UAA), Carter's (CRI), Gildan Activewear (GIL), G-III Apparel Group (GIII), Superior Group of Companies (SGC), Jerash Holdings (US) (JRSH), Centric Brands (CTRC), Sequential Brands Group (SQBG), Ever-Glory International Group (EVK) and Tandy Brands Accessories (TBACQ). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Canada Goose investors own include NVIDIA (NVDA), Micron Technology (MU), Roku (ROKU), Alibaba Group (BABA), Netflix (NFLX), Advanced Micro Devices (AMD), Intel (INTC), Square (SQ), Paypal (PYPL) and Twitter (TWTR).

(GOOS) raised $81 million in an initial public offering (IPO) on Thursday, March 16th 2017. The company issued 7,200,000 shares at $10.50-$12.00 per share. CIBC Capital Markets, Credit Suisse, Goldman, Sachs and RBC Capital Markets served as the underwriters for the IPO and BofA Merrill Lynch, Morgan Stanley, Barclays, BMO, TD, Wells Fargo Securities, Baird and Canaccord Genuity Nomura were co-managers.

Canada Goose trades on the New York Stock Exchange (NYSE) under the ticker symbol "GOOS."

Canada Goose's stock is owned by many different institutional and retail investors. Top institutional shareholders include Morgan Stanley (8.44%), Morgan Stanley (8.44%), Caisse DE Depot ET Placement DU Quebec (3.76%), Tiger Pacific Capital LP (1.47%), The Manufacturers Life Insurance Company (1.29%) and Viking Global Investors LP (1.27%).

GOOS stock was sold by a variety of institutional investors in the last quarter, including Capital International Investors, Mackenzie Financial Corp, Fred Alger Management LLC, Viking Global Investors LP, Connor Clark & Lunn Investment Management Ltd., The Manufacturers Life Insurance Company , Thrivent Financial for Lutherans, and Stony Point Capital LLC.

GOOS stock was purchased by a variety of institutional investors in the last quarter, including Morgan Stanley, Morgan Stanley, Caisse DE Depot ET Placement DU Quebec, Tiger Pacific Capital LP, First Manhattan Co., Timucuan Asset Management Inc. FL, Silvercrest Asset Management Group LLC, and MIK Capital LP.

Shares of GOOS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of GOOS stock can currently be purchased for approximately $20.78.

Canada Goose has a market capitalization of $2.28 billion and generates $632.90 million in revenue each year. The company earns $109.42 million in net income (profit) each year or $1.02 on an earnings per share basis. Canada Goose employs 3,932 workers across the globe.

The official website for Canada Goose is www.canadagoose.com.

Canada Goose's mailing address is 250 BOWIE AVENUE, TORONTO A6, M6E 4Y2. The company can be reached via phone at 416-780-9850 or via email at [email protected]